News
-
-
COMMUNIQUÉ DE PRESSE
Bold Ventures Acquires 100% Ownership of Traxxin Gold Project and Stakes More Ground
Bold Ventures Inc. completes final cash payment for Traxxin Gold Project option agreement, acquires 100% working interest. Expands claim group and joint venture with Lac des Mille Lacs First Nation. Drilling program shows promising results -
COMMUNIQUÉ DE PRESSE
Volatus Aerospace Inc. Receives Approval for BVLOS Flights Without Visual Observers for Its DroneCare Commercial Project
Volatus Aerospace Inc., formerly Drone Delivery Canada, receives Transport Canada approval for BVLOS drone cargo ops on the DroneCare hospital route, enhancing healthcare logistics -
COMMUNIQUÉ DE PRESSE
Volatus Aerospace Inc. reçoit l'approbation pour des vols BVLOS sans observateurs visuels pour son projet commercial DroneCare
Volatus Aerospace Inc. a reçu l'approbation de Transports Canada pour des opérations de cargo par drone au-delà de la ligne de vue visuelle du pilote en utilisant une technologie au sol. Une avancée majeure pour le secteur de la livraison par drone -
-
COMMUNIQUÉ DE PRESSE
Rush Rare Metals Updates Regarding Myriad's Recent Ground Magnetometer Survey at the Copper Mountain Uranium Project, Wyoming
Rush Rare Metals Corp. announces completion of geophysical survey on the 'Canning' area at Copper Mountain uranium property in Wyoming by Myriad Uranium Corp., paving the way for exploration drilling to confirm uranium potential -
-
-
COMMUNIQUÉ DE PRESSE
Clean Air Metals Intersects 51.79 m Grading 4.92 g/t Pt, 4.66 g/t Pd, 1.07% Cu and 0.55% Ni Expanding the Near-Surface High-Grade Mineralization at the Thunder Bay North Project
Clean Air Metals Inc. announces impressive assay results from summer drilling program at Thunder Bay North Critical Minerals Project, showing high-grade mineralization extensions. CEO Mike Garbutt pleased with initial results -
COMMUNIQUÉ DE PRESSE
Eyam Vaccines and Immunotherapeutics Secures Global Health Grant to Advance Gemini Expression Platform
Eyam Vaccines receives grant from Bill & Melinda Gates Foundation to advance Gemini expression platform for durable protein therapeutics, potentially transforming treatment delivery
